In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC

International Journal of Antimicrobial Agents

Volumn 33, Issue 1, 2009, Pages 75-79

  Jesus, Desyreé Murta ^a   Moussatché, Nissin ^a   Damaso, Clarissa R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antiviral agent; Cantagalo virus; Cidofovir; Poxvirus; Smallpox vaccine; Vaccinia virus

Indexed keywords

CIDOFOVIR;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BRAZIL; CANTAGALO VIRUS; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; EPIDEMIC; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; SMALLPOX VIRUS; VACCINIA VIRUS; VIRUS ISOLATION; VIRUS REPLICATION; ZOONOSIS;

ANIMALS; ANTIVIRAL AGENTS; BRAZIL; CATTLE; CATTLE DISEASES; CELL LINE; CERCOPITHECUS AETHIOPS; COMMUNICABLE DISEASES, EMERGING; CYTOSINE; DISEASE OUTBREAKS; HUMANS; KIDNEY; MICROBIAL SENSITIVITY TESTS; PHOSPHONIC ACIDS; SMALLPOX VACCINE; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION; ZOONOSES;

EID: 59549104775     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.07.015     Document Type: Article

References (15)

1. Damaso C.R., Esposito J.J., Condit R.C., and Moussatché N. An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine. Virology 277 (2000) 439-449
2. Trindade G.S., da Fonseca F.G., Marques J.T., Nogueira M.L., Mendes L.C., Borges A.S., et al. Araçatuba virus: a vaccinialike virus associated with infection in humans and cattle. Emerg Infect Dis 9 (2003) 155-160
3. Nagasse-Sugahara T.K., Kisieliu J.J., Ueda-Ito M., Curti S.P., Figueiredo C.A., Cruz A.S., et al. Human vaccinia-like virus outbreaks in São Paulo and Goiás states, Brazil: virus detection, isolation and identification. Rev Inst Med Trop Sao Paulo 46 (2004) 315-322
4. Lobato Z.I., Trindade G.S., Frois M.C., Ribeiro E.B., Dias G.R., Teixeira B.M., et al. Outbreak of exantemal disease caused by vaccinia virus in human and cattle in Zona da Mata region, Minas Gerais. Arq Bras Med Vet Zootech 57 (2005) 423-429
5. Damaso C.R., Reis S.A., Jesus D.M., Lima P.S., and Moussatché N. A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil. Diagn Microbiol Infect Dis 57 (2007) 39-46
6. Prichard M.N., and Kern E.R. Orthopoxvirus targets for the development of antiviral therapies. Curr Drug Targets Infect Disord 5 (2005) 17-28
7. Parrino J., and Graham B.S. Smallpox vaccines: past, present, and future. J Allergy Clin Immunol 118 (2006) 1320-1326
8. Borges M.B., Kato S.E., Damaso C.R., Moussatché N., da Silva Freire M., Lambert Passos S.R., et al. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies. Biologicals 36 (2007) 105-110
9. Fenner F., Henderson D.A., Arita I., Jezek Z., and Ladnyi I.D. Smallpox and its eradication (1988), World Health Organization, Geneva, Switzerland
10. Reis S.A., Moussatche N., and Damaso C.R. FK506 a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against orthopoxvirus infection in cell culture. J Appl Microbiol 100 (2006) 1373-1380
11. Kern E.R., Hartline C., Harden E., Keith K., Rodriguez N., Beadle J.R., et al. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir. Antimicrob Agents Chemother 46 (2002) 991-995
12. Aduma P., Connelly M.C., Srinivas R.V., and Fridland A. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates. Mol Pharmacol 47 (1995) 816-822
13. Quenelle D.C., Collins D.J., and Kern E.R. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir. Antiviral Res 63 (2004) 33-40
14. Scagliarini A., McInnes C.J., Gallina L., Dal Pozzo F., Scagliarini L., Snoeck R., et al. Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs. Antiviral Res 73 (2007) 169-174
15. Calista D. Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study. J Eur Acad Dermatol Venereol 14 (2000) 484-488